6th Mendelian randomization conference
19 to 21 June 2024
Conference venue: Humanities, 7 Woodland Road, Clifton, Bristol, BS8 1TB
The organisers would like to thank all participants for their contribution to the success of this conference, whether as a speaker, poster presenter, chair person, discussant, audience member and whether in person or on line.
We also congratulate our early career researcher prize winners:
Best oral presentation: Marc-André Legault, McGill University “A novel machine learning Mendelian randomization estimator applied for drug target MR of sclerostin inhibition” and Chisom Soremekun, Makerere University “Transethnic Mendelian randomization of hematological traits and type 2 diabetes mellitus
Best poster presentation: Lachlan Gilchrist, King’s College London “Identifying metabolomic risk factors for psychiatric and neurodegenerative disorders: A metabolome-wide mendelian randomisation study” and Muhannad Smadi, Amsterdam UMC “Examining the Impact of Genome-wide Findings for Tobacco Use through GWAS Impact Analysis”
Best people’s choice: Rada Veenemen, University of Amsterdam “The role of sex hormones in severe mental illness: a genetic exploration”
The 6th international conference on Mendelian randomization, will focus on the development and wide-scale use of robust and appropriate Mendelian randomization (MR) methods in all epidemiology research settings. Many epidemiology studies present challenges to the implementation of MR, such as where the number of SNP variants is small, variation in ancestry definitions and for heterogeneous traits. This conference will bring together researchers from across the world to discuss and learn from each other about the development and application of MR.
The conference will be held in the beautiful and vibrant city of Bristol, in the South West of the UK. We will also offer the opportunity to connect to most conference sessions virtually, if you prefer not to travel.
Sponsors
We thank all our sponsors. Their support has enabled us to provide travel awards for early career researchers and researchers from developing countries.
